WallStSmart

Akso Health Group ADR (AHG)vsTalen Energy Corporation (TLN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Talen Energy Corporation generates 17670% more annual revenue ($2.63B vs $14.78M). AHG leads profitability with a 0.0% profit margin vs -8.3%. TLN earns a higher WallStSmart Score of 42/100 (D).

AHG

Avoid

24

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 5.0Quality: 7.5
Piotroski: 2/9Altman Z: 7.29

TLN

Hold

42

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 5.0Quality: 6.0
Piotroski: 4/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2910/10

Safe zone — low bankruptcy risk

TLN2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
58.0%10/10

Revenue surging 58.0% year-over-year

EPS GrowthGrowth
34.5%8/10

Earnings expanding 34.5% YoY

Areas to Watch

AHG4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.2%4/10

4.2% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$807.33M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

TLN4 concerns · Avg: 2.0/10
Price/BookValuation
13.7x4/10

Trading at 13.7x book value

Return on EquityProfitability
-17.7%2/10

ROE of -17.7% — below average capital efficiency

Profit MarginProfitability
-8.3%1/10

Currently unprofitable

Operating MarginProfitability
-36.1%1/10

Operating margin of -36.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : TLN

The strongest argument for TLN centers on Revenue Growth, EPS Growth. Revenue growth of 58.0% demonstrates continued momentum.

Bear Case : AHG

The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.

Bear Case : TLN

The primary concerns for TLN are Price/Book, Return on Equity, Profit Margin.

Key Dynamics to Monitor

AHG profiles as a value stock while TLN is a hypergrowth play — different risk/reward profiles.

TLN carries more volatility with a beta of 1.61 — expect wider price swings.

TLN is growing revenue faster at 58.0% — sustainability is the question.

TLN generates stronger free cash flow (240M), providing more financial flexibility.

Bottom Line

TLN scores higher overall (42/100 vs 24/100) and 58.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.

Visit Website →

Talen Energy Corporation

UTILITIES · UTILITIES - INDEPENDENT POWER PRODUCERS · USA

None

Want to dig deeper into these stocks?